177Lu-PSMA-617 radioligand therapy in mCRPC: ready for phase III trial?
Crossref DOI link: https://doi.org/10.1007/s00259-017-3892-0
Published Online: 2017-11-21
Published Print: 2018-03
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Rahbar, Kambiz http://orcid.org/0000-0002-4591-4055
Ahmadzadehfar, Hojjat
Boegemann, Martin
License valid from 2017-11-21